Cargando…

Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells

Triple-negative breast cancer comprises approximately 15–20% of all breast cancers diagnosed and is nearly twice as common in black women than white women in the United States. We evaluated the effects of two epigenetic-modifying compounds on markers of growth potential in several triple-negative br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewis, Kayla A., Jordan, Harrison R., Tollefsbol, Trygve O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356328/ https://www.ncbi.nlm.nih.gov/pubmed/30591655 http://dx.doi.org/10.3390/cancers11010023

Ejemplares similares

Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
por: Sharma, Manvi, et al.
Publicado: (2021)

Vorinostat (SAHA) and Breast Cancer: An Overview
por: Wawruszak, Anna, et al.
Publicado: (2021)

A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells
por: Royston, Kendra J., et al.
Publicado: (2017)

Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2020)

Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms
por: Lewis, Kayla A., et al.
Publicado: (2016)

A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells
por: Kala, Rishabh, et al.
Publicado: (2016)

Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer
por: Kala, Rishabh, et al.
Publicado: (2015)

CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression
por: Das, Amlan, et al.
Publicado: (2021)

Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression
por: Li, Yuanyuan, et al.
Publicado: (2017)

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
por: Min, Ahrum, et al.
Publicado: (2015)

Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications
por: Meeran, Syed M., et al.
Publicado: (2012)

Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic–Mediating Machinery
por: Gao, Yifeng, et al.
Publicado: (2018)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Professor Kshitish Chandra Saha
por: Coondoo, Arijit
Publicado: (2016)

First person – Santu Saha
Publicado: (2023)

Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer
por: Krakowsky, Rosanna H. E., et al.
Publicado: (2015)

Impact of Stilbenes as Epigenetic Modulators of Breast Cancer Risk and Associated Biomarkers
por: Ganguly, Sebanti, et al.
Publicado: (2021)

Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment
por: Wu, Huixin, et al.
Publicado: (2022)

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
por: You, Kyu Sic, et al.
Publicado: (2021)

Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells
por: Li, Yuanyuan, et al.
Publicado: (2010)

The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation
por: Paul, Bidisha, et al.
Publicado: (2018)

EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome
por: Gonzalez Suarez, Narjara, et al.
Publicado: (2022)

MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
por: Rahman, Mohammad Mijanur, et al.
Publicado: (2019)

TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA
por: Han, Han, et al.
Publicado: (2017)

Triple-negative breast cancer and the potential for targeted therapy
por: Jhan, Jing-Ru, et al.
Publicado: (2017)

Suppressive Effects of EGCG on Cervical Cancer
por: Wang, Ying-Qi, et al.
Publicado: (2018)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells
por: Grabarska, Aneta, et al.
Publicado: (2017)

Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals
por: Li, Yuanyuan, et al.
Publicado: (2016)

Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
por: Li, Yuanyuan, et al.
Publicado: (2013)

Identification of candidate genes associated with triple negative breast cancer
por: Player, Audrey, et al.
Publicado: (2017)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
por: Meeran, Syed M., et al.
Publicado: (2010)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
por: Anselmino, L. E., et al.
Publicado: (2023)

Meghnad Saha: his life in science and politics
por: Naik, Pramod V
Publicado: (2017)

Solar models using the SAHA-S equation of state
por: Ayukov, S V, et al.
Publicado: (2004)

Phosphorus containing analogues of SAHA as inhibitors of HDACs
por: Pun, Michael D., et al.
Publicado: (2022)

HDAC inhibition potentiates immunotherapy in triple negative breast cancer
por: Terranova-Barberio, Manuela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_17cnckqoi00puuurtuetpl5a3r